Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label attachment file name title
tabling member	label

Search

390600

registered interest
date	16/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Anaemia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how they propose to alert medical practitioners to the severe and irreversible nerve damage that can occur when pernicious anaemia is misdiagnosed.
tabling member printed	The Countess of Mar
uin	HL1540
answer	answer is ministerial correction date of answer 24/07/2015 answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p> answering member printed Lord Prior of Brampton question first answered 24/07/2015 13:21:19 question first ministerially corrected 14/10/2015 11:21:19 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia previous answer version 17460 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia
tabling member	1861 label Biography information for The Countess of Mar

390798

registered interest
date	16/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Loneliness: Older People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to reduce the number of older people experiencing loneliness.
tabling member constituency	South Ribble
tabling member printed	Seema Kennedy
uin	7567
answer	answer is ministerial correction date of answer 21/07/2015 answer text <p>My Rt. hon. Friend the Secretary of State for Health set out in his speech to the Local Government Association on 1 July that we all have a responsibility at an individual, family, and community level to identify people with care needs such as loneliness and provide support and improve their wellbeing.</p><p> </p><p> </p><p> </p><p>Through the Care Act 2014 the Department has required local authorities to have measures in place to identify people in their area who would benefit from universal services to help reduce, delay or prevent needs for care and support. This includes needs that may arise from social isolation.</p><p> </p><p> </p><p> </p><p>The Department has supported a ‘digital toolkit’ for local commissioners, which was developed by the Campaign to End Loneliness. Since its launch in July 2012, the toolkit has been supporting commissioners in understanding, mapping and commissioning for loneliness and social isolation in their communities.</p><p> </p><p> </p><p> </p><p>Alongside work to build our understanding of the issue and expanding the evidence base, we have launched the Prevention Library where local authorities can exchange ideas and experience of the impact of information, advice and befriending services.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 21/07/2015 12:11:53 answering member 1201 label Biography information for Alistair Burt
tabling member	4455 label Biography information for Seema Kennedy

390815

registered interest
date	16/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Databases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many GP practices in each pathfinder area have signed up to care.data.
tabling member constituency	Copeland
tabling member printed	Mr Jamie Reed
uin	7630
answer	answer is ministerial correction date of answer 23/07/2015 answer text <p>The care.data pathfinder clinical commissioning groups (CCGs) are, Blackburn with Darwen, Leeds North, Leeds West, Leeds South and East, West Hampshire and Somerset.</p><p> </p><p> </p><p> </p><p>The number of general practitioner practices who have signed up as pathfinders across West Hampshire, Somerset and Blackburn with Darwen is over 70%.</p><p> </p><p> </p><p> </p><p>The numbers are as follows:</p><p> </p><p> </p><p> </p><p>Blackburn with Darwen – 23</p><p> </p><p>Somerset - 47</p><p> </p><p>West Hampshire - 31</p><p> </p><p> </p><p> </p><p>The three Leeds CCGs are still recruiting practices.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 23/07/2015 10:09:40 answering member 4020 label Biography information for George Freeman
tabling member	1503 label Biography information for Mr Jamie Reed

389572

registered interest
date	13/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sunscreens: VAT
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will assess the potential effect of a reduction in VAT on sunscreen on public health.
tabling member constituency	Swansea East
tabling member printed	Carolyn Harris
uin	6780
answer	answer is ministerial correction date of answer 21/07/2015 answer text <p>We have made no assessment of the potential effect of reduction in VAT on sunscreen on public health.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 21/07/2015 15:32:14 answering member 3918 label Biography information for Jane Ellison
tabling member	4480 label Biography information for Carolyn Harris

386702

registered interest
date	30/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medicine: Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average cost to the taxpayer is of training someone to become a doctor in the UK.
tabling member constituency	East Yorkshire
tabling member printed	Sir Greg Knight
uin	4761
answer	answer is ministerial correction date of answer 08/07/2015 answer text <p>The Department does not hold information on the average cost to the taxpayer of training someone to become a doctor in the United Kingdom.</p><br /> <br /> <br /><p>The Personal Social Services Research Unit at the University of Kent estimates within their report ‘Unit Costs of Health and Social Care 2014’, published March 2014, that the average cost in <ins class="ministerial">2013/14 </ins><del class="ministerial">2014/15</del> of training to become a general practitioner is £485,390 with the consultant training cost being £726,551. These figures reflect the pre-registration costs of tuition, living expenses/lost production and clinical placements and the post-graduate costs of tuition and replacement costs not the average cost to the taxpayer.</p><br /> answering member constituency Ipswich answering member printed Ben Gummer question first answered 08/07/2015 13:27:38 question first ministerially corrected 02/11/2015 11:19:49 answering member 3988 label Biography information for Ben Gummer previous answer version 12875 answering member constituency Ipswich answering member printed Ben Gummer answering member 3988 label Biography information for Ben Gummer
tabling member	1200 label Biography information for Sir Greg Knight

384563

registered interest
date	22/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospitals: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many hospital trusts were in special measures in (a) 2012, (b) 2013 and (c) 2014.
tabling member constituency	Carlisle
tabling member printed	John Stevenson
uin	3421
answer	answer is ministerial correction date of answer 30/06/2015 answer text <p>Following the publication in February 2013 of Robert Francis’s report into care at Mid Staffordshire NHS Foundation Trust, Sir Bruce Keogh led a review of 14 trusts that had high mortality rates. The Keogh Review identified significant problems relating to quality and safety and/or leadership in all of these trusts and in July 2013, the decision was taken to place 11 trusts into ‘special measures’. Special measures is a robust and targeted regime agreed between the Care Quality Commission, Monitor and the NHS Trust Development Authority.</p><p> </p><p> </p><p> </p><p>A total of 14 trusts were placed in special measures in 2013. In 2014 an additional four trusts entered special measures and six trusts exited the regime.</p><p> </p><p> </p><p> </p><p>To date a total of 21 trusts have been placed in special measures and seven have exited the regime, having shown notable improvements. We believe that special measures is an effective way of confronting poor care and improving performance, often in hospitals that had shown significant issues including before 2010.&quot;</p><p> </p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 30/06/2015 13:04:49 answering member 3988 label Biography information for Ben Gummer
tabling member	3942 label Biography information for John Stevenson

383899

registered interest
date	18/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bupropion: Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many prescriptions were issued for bupropion in each year since 2001.
tabling member constituency	Ayr, Carrick and Cumnock
tabling member printed	Corri Wilson
uin	3204
answer	answer is ministerial correction date of answer 25/06/2015 answer text <p>Information is not collected centrally on the numbers of prescriptions issued. However, information is available on the number of bupropion hydrochloride prescription items dispensed.</p><p> </p><p> </p><p> </p><table><tbody><tr><td colspan="2"><p>Number of bupropion hydrochloride prescription items written in the United Kingdom and dispensed in the community in England - 2001 to 2014</p></td></tr><tr><td><p>Year</p></td><td><p>Items (000’s)</p></td></tr><tr><td><p>2001</p></td><td><p>298.8</p></td></tr><tr><td><p>2002</p></td><td><p>131.0</p></td></tr><tr><td><p>2003</p></td><td><p>111.8</p></td></tr><tr><td><p>2004</p></td><td><p>136.8</p></td></tr><tr><td><p>2005</p></td><td><p>131.9</p></td></tr><tr><td><p>2006</p></td><td><p>116.9</p></td></tr><tr><td><p>2007</p></td><td><p>129.9</p></td></tr><tr><td><p>2008</p></td><td><p>62.1</p></td></tr><tr><td><p>2009</p></td><td><p>51.1</p></td></tr><tr><td><p>2010</p></td><td><p>39.3</p></td></tr><tr><td><p>2011</p></td><td><p>32.3</p></td></tr><tr><td><p>2012</p></td><td><p>27.8</p></td></tr><tr><td><p>2013</p></td><td><p>23.7</p></td></tr><tr><td><p>2014</p></td><td><p>22.0</p></td></tr></tbody></table><p> </p><p><em>Source:</em> Prescription Cost Analysis provided by the Health and Social Care Information Centre</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 25/06/2015 14:23:45 answering member 1201 label Biography information for Alistair Burt
tabling member	4448 label Biography information for Corri Wilson

381180

registered interest
date	15/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to improve support for children and young people with mental health issues.
tabling member constituency	Hazel Grove
tabling member printed	William Wragg
uin	2461
answer	answer is ministerial correction date of answer 23/06/2015 answer text <p>This Government is committed to improving children and young people’s mental health and wellbeing. The Department is working with NHS England and other partners to enhance significantly the support offered to children and young people.</p><p> </p><p> </p><p> </p><p>We are already making progress in a number of areas including:</p><p> </p><p>- The extension and expansion of the children and young people’s Improving Access to Psychological Therapies programme.</p><p> </p><p>- Joint training and piloting of staff in schools and local mental health services to strengthen the mental health support and advice available in schools.</p><p> </p><p> </p><p> </p><p>The Department is also commissioning the first prevalence survey of child and adolescent mental health in over 10 years. The survey will provide an accurate assessment of how many children and young people are living with mental health issues. Publication is anticipated in 2017.</p><p> </p><p> </p><p> </p><p>In addition, NHS England is leading work to develop new access and waiting time standards for eating disorder services.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 23/06/2015 13:17:56 answering member 1201 label Biography information for Alistair Burt
tabling member	4429 label Biography information for Mr William Wragg

348047

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much the treatment of hidradenitis suppurativa cost the NHS in England in (a) 2012, (b) 2013 and (c) 2014.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	745
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 746 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford

348048

registered interest
date	02/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to support patients with hidradenitis suppurativa.
tabling member constituency	Mole Valley
tabling member printed	Sir Paul Beresford
uin	746
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurative (HS) affects around 90,000 people in England and can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin.</p><p> </p><p> </p><p> </p><p>For those patients with the most serious forms of HS who cannot be managed through routine access treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with a involvement of a range of health and care professionals, subject to that patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p><p> </p><p> </p><p>The Department does not hold data on spending on individual dermatological conditions. However, the latest NHS Programme Budgeting data, which is for 2012-13, shows that the total spend on dermatology (excluding burns) was £1.98 billion.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 745 question first answered 08/06/2015 10:56:15 answering member 3918 label Biography information for Jane Ellison
tabling member	103 label Biography information for Sir Paul Beresford